How can specific NGS assay content, chemistry, and analysis make a difference for heme malignancy answers? Hear from experts at Duke on their experience implementing Archer FUSIONPlexTM and VARIANTPlexTM custom NGS assays for profiling heme malignancies. Learn why they chose these panels, how they were implemented in the lab, and their experience with the chemistry, workflows, and analysis software. Case studies demonstrating the difference these assays make for heme malignancy answers will be presented.
Analytical Specialist
Division of Molecular Pathology, Genetics and Genomics
Duke University Health System
Laboratory Genetics & Genomics Fellow
Division of Molecular Pathology, Genetics and Genomics
Duke University Health System
Director of Product Management, NGS Software
Integrated DNA Technologies